technology

Can Denmark's world beating drugs maker stay ahead?


“I think 90% of pharmaceutical spend in the UK, and I’m pretty sure it’s similar in the US, is for generics… so, you [the original inventor] may well retain market share, but the price will fall,” says Graham Cookson chief executive of the Office of Health Economics, the world’s oldest health economics research organisation.



READ SOURCE

Readers Also Like:  Figma CEO Dylan Field laments demise of $20 billion deal with Adobe

This website uses cookies. By continuing to use this site, you accept our use of cookies.